About Dual specificity protein phosphatase 6
Dual specificity protein phosphatase 6 (DUSP6) is a protein
from Homo sapiens identified by UniProt accession
Q16828, 381 residues long.
MolForge cross-references it against 0 known binders and
287 disease associations.
Target properties
| Protein name | Dual specificity protein phosphatase 6 |
| UniProt accession | Q16828 |
| Gene | DUSP6 |
| Organism | Homo sapiens |
| Length | 381 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (287)
Diseases linked to this target (Open Targets).
- Kallmann syndrome · score 0.58
- body mass index · score 0.44
- body fat percentage · score 0.44
- attention deficit hyperactivity disorder · score 0.43
- lean body mass · score 0.41
- mathematical ability · score 0.40
- self reported educational attainment · score 0.39
- aspartate aminotransferase measurement · score 0.38
- fat body mass · score 0.38
- hypogonadotropic hypogonadism · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16828-F1 | alphafold | PREDICTED | 75.24 | — |
Amino-acid sequence (381 residues)
MIDTLRPVPF ASEMAISKTV AWLNEQLELG NERLLLMDCR PQELYESSHI ESAINVAIPG IMLRRLQKGN LPVRALFTRG EDRDRFTRRC GTDTVVLYDE SSSDWNENTG GESVLGLLLK KLKDEGCRAF YLEGGFSKFQ AEFSLHCETN LDGSCSSSSP PLPVLGLGGL RISSDSSSDI ESDLDRDPNS ATDSDGSPLS NSQPSFPVEI LPFLYLGCAK DSTNLDVLEE FGIKYILNVT PNLPNLFENA GEFKYKQIPI SDHWSQNLSQ FFPEAISFID EARGKNCGVL VHCLAGISRS VTVTVAYLMQ KLNLSMNDAY DIVKMKKSNI SPNFNFMGQL LDFERTLGLS SPCDNRVPAQ QLYFTTPSNQ NVYQVDSLQS T
Explore Dual specificity protein phosphatase 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets